Strata Critical Medical, Inc.
SRTA
$4.34
$0.040.93%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 36.70% | 17.05% | 5.42% | 14.49% | -49.52% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.70% | 17.05% | 5.42% | 14.49% | -49.52% |
| Cost of Revenue | 31.97% | 31.15% | 2.30% | 8.58% | -48.89% |
| Gross Profit | 54.69% | -15.36% | 18.14% | 39.72% | -51.81% |
| SG&A Expenses | -16.26% | 966.99% | -3.04% | -7.13% | -36.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.02% | 67.54% | 0.83% | 2.70% | -45.51% |
| Operating Income | 91.67% | -113.88% | 23.16% | 43.17% | 7.00% |
| Income Before Tax | -71.62% | -224.46% | 18.71% | 71.69% | -1,446.17% |
| Income Tax Expenses | -- | -- | 79.76% | 89.74% | -- |
| Earnings from Continuing Operations | -71.62% | -235.22% | 17.50% | 71.15% | -2,047.06% |
| Earnings from Discontinued Operations | 1,726.11% | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 3,038.38% | 66.95% | 17.50% | 71.15% | -776.12% |
| EBIT | 91.67% | -113.88% | 23.16% | 43.17% | 7.00% |
| EBITDA | 97.20% | -88.72% | 28.86% | 48.02% | -0.77% |
| EPS Basic | 2,885.20% | 68.64% | 21.82% | 72.53% | -794.44% |
| Normalized Basic EPS | 110.07% | -94.95% | 22.75% | 30.76% | -1,348.57% |
| EPS Diluted | 2,874.00% | 67.74% | 27.17% | 72.53% | -857.58% |
| Normalized Diluted EPS | 110.07% | -94.95% | 22.75% | 30.76% | -1,465.63% |
| Average Basic Shares Outstanding | 5.65% | 5.09% | 5.40% | 5.04% | 5.27% |
| Average Diluted Shares Outstanding | 5.65% | 5.09% | 5.40% | 5.04% | -3.66% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |